Platte River Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Platte River Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$1.94M	Sell	34,400 -16,350	-32%	-$1.06M	1.79%	15
2015 Q2	$3M	Sell	50,750 -300	-0.6%	-$18.5K	1.51%	14
2015 Q1	$3.18M	Sell	51,050 -4,000	-7%	-$233K	1.43%	16
2014 Q4	$3.17M	Sell	55,050 -13,460	-20%	-$750K	1.18%	23
2014 Q3	$3.68M	Sell	68,510 -24,820	-27%	-$1.31M	0.95%	36
2014 Q2	$4.89M	Buy	93,330 +310	+0.3%	+$15.8K	0.74%	52
2014 Q1	$4.92M	Sell	93,020 -41,105	-31%	-$1.9M	0.67%	56
2013 Q4	$5.38M	Buy	134,125 +15,040	+13%	+$592K	0.69%	49
2013 Q3	$4.5M	Sell	119,085 -6,030	-5%	-$235K	0.56%	68
2013 Q2	$4.91M	Buy	+125,115	New	+$4.87M	0.57%	62

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Platte River Capital's TEVA Position: Q3 2015 in Review

Platte River Capital reduced its Teva Pharmaceuticals (TEVA) stake by 32% in Q3 2015, selling an estimated $1.06M and leaving 34,400 shares worth $1.94M. The position accounts for 1.79% of the portfolio, ranked #15.

Platte River Capital first reported a position in TEVA in Q2 2013 and has held it in 10 quarters since. The position peaked at $5.38M in Q4 2013. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

Platte River Capital held 34,400 shares of Teva Pharmaceuticals worth $1.94M as of Q3 2015.
Platte River Capital sold 16,350 Teva Pharmaceuticals shares in Q3 2015, an estimated $1.06M.
Teva Pharmaceuticals made up 1.79% of Platte River Capital's portfolio in Q3 2015, its #15 holding.
Platte River Capital first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
Platte River Capital's Teva Pharmaceuticals position peaked at $5.38M in Q4 2013.
823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.